ID

30482

Descrição

Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs; ODM derived from: https://clinicaltrials.gov/show/NCT00633399

Link

https://clinicaltrials.gov/show/NCT00633399

Palavras-chave

Versões (1)
  1. 08/06/2018 08/06/2018 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

8 de junho de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Major Depressive Disorder NCT00633399

Inglês

Eligibility Major Depressive Disorder NCT00633399

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent.
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
men or women, 18-65 years of age.
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
mdd, current, according to dsm-iv criteria and as diagnosed by the scid- i/p during the screen and baseline visit of phase 1.
Descrição

Major Depressive Disorder

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1269683
a ham-d-17 score > 14 during the screen and baseline visit of phase 1.
Descrição

Hamilton Depression Rating Scale 17 Item Clinical Classification

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3639712
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant women or women of child bearing potential who are not using a medically accepted means of contraception (oral contraceptive or implant, condom, diaphragm, spermicide, intrauterine
Descrição

Pregnancy | Childbearing Potential Contraceptive methods Absent | Oral contraception | Contraceptive implant | Female Condoms | Vaginal contraceptive diaphragm | Vaginal Spermicides | Intrauterine Devices

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0332197
UMLS CUI [3]
C0029151
UMLS CUI [4]
C1657106
UMLS CUI [5]
C0221829
UMLS CUI [6]
C0042241
UMLS CUI [7]
C0087145
UMLS CUI [8]
C0021900
device, tubal ligation, or partner with vasectomy).
Descrição

Tubal Ligation | Partner had vasectomy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0520483
UMLS CUI [2]
C0420842
serious suicide or homicide risk, as assessed by evaluating clinician.
Descrição

At risk for suicide Serious | Homicide At risk Serious

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0563664
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C0019872
UMLS CUI [2,2]
C1444641
UMLS CUI [2,3]
C0205404
unstable medical illness including cardiovascular, hepatic, renal, respiratory, endocrine, neurological, or hematological disease or uncontrolled seizure disorder.
Descrição

Illness Unstable | Cardiovascular Diseases | Liver diseases | Kidney Diseases | Respiration Disorders | Endocrine System Diseases | Nervous system disorder | Hematological Disease | Epilepsy Uncontrolled

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0443343
UMLS CUI [2]
C0007222
UMLS CUI [3]
C0023895
UMLS CUI [4]
C0022658
UMLS CUI [5]
C0035204
UMLS CUI [6]
C0014130
UMLS CUI [7]
C0027765
UMLS CUI [8]
C0018939
UMLS CUI [9,1]
C0014544
UMLS CUI [9,2]
C0205318
history of multiple adverse drug reactions or allergy to the study drug.
Descrição

Adverse reaction to drug Multiple | Hypersensitivity Investigational New Drugs

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0041755
UMLS CUI [1,2]
C0439064
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013230
the following dsm-iv diagnoses: substance use disorders active within the last six months, any bipolar disorder (current or past), any psychotic disorder (current or past).
Descrição

Substance Use Disorders | Bipolar Disorder | Psychotic Disorders

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0005586
UMLS CUI [3]
C0033975
patients requiring excluded medications (see appendix 1 for details).
Descrição

Patient need for Pharmaceutical Preparations Excluded

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0332196
psychotic features in the current episode or a history of psychotic features.
Descrição

Feature Psychotic Depressive episode | Feature Psychotic

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2348519
UMLS CUI [1,2]
C0033975
UMLS CUI [1,3]
C0349217
UMLS CUI [2,1]
C2348519
UMLS CUI [2,2]
C0033975
prior course of ziprasidone, or intolerance to ziprasidone at any dose.
Descrição

Ziprasidone | Intolerance to Ziprasidone Dose Any

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0380393
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0380393
UMLS CUI [2,3]
C0178602
UMLS CUI [2,4]
C1552551
any investigational psychotropic drug within the last 3 months.
Descrição

Psychotropic Drug Investigational

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0033978
UMLS CUI [1,2]
C1517586
have failed more than 3 adequate antidepressant trials during the current mde. some examples of adequate dosage of an antidepressant trial include either > 150 mg of imipramine (or its tricyclic equivalent), > 60 mg of phenelzine (or its monoamine oxidase inhibitor equivalent), > 20 mg of fluoxetine (or its ssri-equivalent), > 150mg of bupropion, > 300mg of trazodone (or nefazodone), >75 mg of venlafaxine, >60mg of duloxetine, or > 15mg of mirtazapine. a trial of adequate duration was defined as one during which the patient was on any given antidepressant at an adequate dose for a minimum of 6 weeks.
Descrição

Major depressive episode | Antidepressive Agents | Therapeutic procedure Quantity | Imipramine Dosage | Tricyclic Antidepressive Agents Equivalent | Phenelzine Dosage | Monoamine Oxidase Inhibitors Equivalent | Fluoxetine Dosage | Selective Serotonin Reuptake Inhibitors Equivalent | Bupropion Dosage | Trazodone Dosage | Nefazodone Dosage | Venlafaxine Dosage | Duloxetine Dosage | Mirtazapine Dosage

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0024517
UMLS CUI [2]
C0003289
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C1265611
UMLS CUI [4,1]
C0020934
UMLS CUI [4,2]
C0178602
UMLS CUI [5,1]
C0003290
UMLS CUI [5,2]
C0205163
UMLS CUI [6,1]
C0031392
UMLS CUI [6,2]
C0178602
UMLS CUI [7,1]
C0026457
UMLS CUI [7,2]
C0205163
UMLS CUI [8,1]
C0016365
UMLS CUI [8,2]
C0178602
UMLS CUI [9,1]
C0360105
UMLS CUI [9,2]
C0205163
UMLS CUI [10,1]
C0085208
UMLS CUI [10,2]
C0178602
UMLS CUI [11,1]
C0040805
UMLS CUI [11,2]
C0178602
UMLS CUI [12,1]
C0068485
UMLS CUI [12,2]
C0178602
UMLS CUI [13,1]
C0078569
UMLS CUI [13,2]
C0178602
UMLS CUI [14,1]
C0245561
UMLS CUI [14,2]
C0178602
UMLS CUI [15,1]
C0049506
UMLS CUI [15,2]
C0178602
Voltar ao início da página

Similar models

Eligibility Major Depressive Disorder NCT00633399

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written informed consent.
boolean
C0021430 (UMLS CUI [1])
Age
Item
men or women, 18-65 years of age.
boolean
C0001779 (UMLS CUI [1])
Major Depressive Disorder
Item
mdd, current, according to dsm-iv criteria and as diagnosed by the scid- i/p during the screen and baseline visit of phase 1.
boolean
C1269683 (UMLS CUI [1])
Hamilton Depression Rating Scale 17 Item Clinical Classification
Item
a ham-d-17 score > 14 during the screen and baseline visit of phase 1.
boolean
C3639712 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Childbearing Potential Contraceptive methods Absent | Oral contraception | Contraceptive implant | Female Condoms | Vaginal contraceptive diaphragm | Vaginal Spermicides | Intrauterine Devices
Item
pregnant women or women of child bearing potential who are not using a medically accepted means of contraception (oral contraceptive or implant, condom, diaphragm, spermicide, intrauterine
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0029151 (UMLS CUI [3])
C1657106 (UMLS CUI [4])
C0221829 (UMLS CUI [5])
C0042241 (UMLS CUI [6])
C0087145 (UMLS CUI [7])
C0021900 (UMLS CUI [8])
Tubal Ligation | Partner had vasectomy
Item
device, tubal ligation, or partner with vasectomy).
boolean
C0520483 (UMLS CUI [1])
C0420842 (UMLS CUI [2])
At risk for suicide Serious | Homicide At risk Serious
Item
serious suicide or homicide risk, as assessed by evaluating clinician.
boolean
C0563664 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0019872 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C0205404 (UMLS CUI [2,3])
Illness Unstable | Cardiovascular Diseases | Liver diseases | Kidney Diseases | Respiration Disorders | Endocrine System Diseases | Nervous system disorder | Hematological Disease | Epilepsy Uncontrolled
Item
unstable medical illness including cardiovascular, hepatic, renal, respiratory, endocrine, neurological, or hematological disease or uncontrolled seizure disorder.
boolean
C0221423 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0035204 (UMLS CUI [5])
C0014130 (UMLS CUI [6])
C0027765 (UMLS CUI [7])
C0018939 (UMLS CUI [8])
C0014544 (UMLS CUI [9,1])
C0205318 (UMLS CUI [9,2])
Adverse reaction to drug Multiple | Hypersensitivity Investigational New Drugs
Item
history of multiple adverse drug reactions or allergy to the study drug.
boolean
C0041755 (UMLS CUI [1,1])
C0439064 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Substance Use Disorders | Bipolar Disorder | Psychotic Disorders
Item
the following dsm-iv diagnoses: substance use disorders active within the last six months, any bipolar disorder (current or past), any psychotic disorder (current or past).
boolean
C0038586 (UMLS CUI [1])
C0005586 (UMLS CUI [2])
C0033975 (UMLS CUI [3])
Patient need for Pharmaceutical Preparations Excluded
Item
patients requiring excluded medications (see appendix 1 for details).
boolean
C0686904 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
Feature Psychotic Depressive episode | Feature Psychotic
Item
psychotic features in the current episode or a history of psychotic features.
boolean
C2348519 (UMLS CUI [1,1])
C0033975 (UMLS CUI [1,2])
C0349217 (UMLS CUI [1,3])
C2348519 (UMLS CUI [2,1])
C0033975 (UMLS CUI [2,2])
Ziprasidone | Intolerance to Ziprasidone Dose Any
Item
prior course of ziprasidone, or intolerance to ziprasidone at any dose.
boolean
C0380393 (UMLS CUI [1])
C1744706 (UMLS CUI [2,1])
C0380393 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C1552551 (UMLS CUI [2,4])
Psychotropic Drug Investigational
Item
any investigational psychotropic drug within the last 3 months.
boolean
C0033978 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
Major depressive episode | Antidepressive Agents | Therapeutic procedure Quantity | Imipramine Dosage | Tricyclic Antidepressive Agents Equivalent | Phenelzine Dosage | Monoamine Oxidase Inhibitors Equivalent | Fluoxetine Dosage | Selective Serotonin Reuptake Inhibitors Equivalent | Bupropion Dosage | Trazodone Dosage | Nefazodone Dosage | Venlafaxine Dosage | Duloxetine Dosage | Mirtazapine Dosage
Item
have failed more than 3 adequate antidepressant trials during the current mde. some examples of adequate dosage of an antidepressant trial include either > 150 mg of imipramine (or its tricyclic equivalent), > 60 mg of phenelzine (or its monoamine oxidase inhibitor equivalent), > 20 mg of fluoxetine (or its ssri-equivalent), > 150mg of bupropion, > 300mg of trazodone (or nefazodone), >75 mg of venlafaxine, >60mg of duloxetine, or > 15mg of mirtazapine. a trial of adequate duration was defined as one during which the patient was on any given antidepressant at an adequate dose for a minimum of 6 weeks.
boolean
C0024517 (UMLS CUI [1])
C0003289 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0020934 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0003290 (UMLS CUI [5,1])
C0205163 (UMLS CUI [5,2])
C0031392 (UMLS CUI [6,1])
C0178602 (UMLS CUI [6,2])
C0026457 (UMLS CUI [7,1])
C0205163 (UMLS CUI [7,2])
C0016365 (UMLS CUI [8,1])
C0178602 (UMLS CUI [8,2])
C0360105 (UMLS CUI [9,1])
C0205163 (UMLS CUI [9,2])
C0085208 (UMLS CUI [10,1])
C0178602 (UMLS CUI [10,2])
C0040805 (UMLS CUI [11,1])
C0178602 (UMLS CUI [11,2])
C0068485 (UMLS CUI [12,1])
C0178602 (UMLS CUI [12,2])
C0078569 (UMLS CUI [13,1])
C0178602 (UMLS CUI [13,2])
C0245561 (UMLS CUI [14,1])
C0178602 (UMLS CUI [14,2])
C0049506 (UMLS CUI [15,1])
C0178602 (UMLS CUI [15,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial